All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

267

Reset

267 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • EHT102Phase 21 trial

    Shanghai Euhearing Therapeutics Co., Ltd · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

  • EIS-12656Phase 21 trial

    Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency

  • EP0042Phase 21 trial

    Ellipses Pharma · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes

  • EPI-321Phase 21 trial

    Epicrispr Biotechnologies, Inc. · Facioscapulohumeral Muscular Dystrophy

  • EXG110Phase 21 trial

    Guangzhou Jiayin Biotech Ltd · Fabry Disease

  • GEn-1124Phase 21 trial

    GEn1E Lifesciences · Respiratory Distress Syndrome, Acute

  • GKL-006RTUPhase 21 trial

    Beijing Gene Key Life Technology Co., Ltd · ARDS (Acute Respiratory Distress Syndrome)

  • GTX-102Phase 21 trial

    Ultragenyx Pharmaceutical Inc · Angelman Syndrome

  • HGT-1110Recombinant human arylsulfatase APhase 21 trial

    Takeda · Metachromatic Leukodystrophy (MLD)

  • HM15136Phase 21 trial

    Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism

  • HM15421GC1134APhase 21 trial

    GC Biopharma Corp · Fabry Disesase

  • ION337Phase 21 trial

    Ionis Pharmaceuticals · Dravet Syndrome

  • ION440Phase 21 trial

    Ionis Pharmaceuticals · Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

  • IW-6463CY6463, zagociguatPhase 21 trial

    Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

  • JR-171lepunafuspPhase 21 trial

    JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis I

  • JR-441posnafuspPhase 21 trial

    JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-A

  • KRRO-121Phase 21 trial

    Korro Bio, Inc. · Urea Cycle Disorders, Inborn, Urea Cycle Disorders, Ornithine Transcarbamylase (OTC) Deficiency

  • lacutamabIPH4102Phase 21 trial

    Innate Pharma · Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome

  • LB-100Phase 21 trial

    Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MK-1439APhase 21 trial

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection

  • MNV-201Phase 21 trial

    Minovia Therapeutics Ltd. · Mitochondrial Diseases, Pearson Syndrome

  • MZE782Phase 21 trial

    Maze Therapeutics · Phenylketonuria (PKU)

  • NBIP-01435Phase 21 trial

    Neurocrine Biosciences · Congenital Adrenal Hyperplasia

  • NGGT001Phase 21 trial

    NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy

  • NOE-115Phase 21 trial

    Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes

  • NS-050NCNP-03Phase 21 trial

    NS Pharma, Inc. · Duchenne Muscular Dystrophy

  • NS-229Phase 21 trial

    NS Pharma, Inc. · Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome

  • OCU400Phase 21 trial

    Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis

  • OpCT-001Phase 21 trial

    BlueRock Therapeutics · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), Usher Syndrome

  • OrticumabMLDL1278a, BI204Phase 21 trial

    Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation

  • PBGM01Phase 21 trial

    Gemma Biotherapeutics · GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2

  • PBSS1113Phase 21 trial

    Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)

  • PM647aPhase 21 trial

    Prime Medicine, Inc. · Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease, Alpha-1 Antitrypsin Deficiency (AATD)

  • PYC-001Phase 21 trial

    PYC Therapeutics · OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies

  • QLS2319Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Cancer Cachexia, Cancer Cachexia Syndrome

  • QR-1123Phase 21 trial

    ProQR Therapeutics · Autosomal Dominant Retinitis Pigmentosa, Eye Diseases, Eye Diseases, Hereditary

  • RenadirsenDS-5141bPhase 21 trial

    Daiichi Sankyo · Duchenne Muscular Dystrophy

  • RinvaterceptKER-065Phase 21 trial

    Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy

  • RLY-2608Phase 21 trial

    Relay Therapeutics, Inc. · PIK3CA-Related Overgrowth Spectrum (PROS), Lymphatic Malformations, Vascular Malformations

  • RN0361Phase 21 trial

    Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome

  • RSLV-132Phase 21 trial

    Resolve Therapeutics · Primary Sjögren Syndrome

  • S241656Phase 21 trial

    Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • S247240Phase 21 trial

    Institut de Recherches Internationales Servier (I.R.I.S.) · Fragile X Syndrome (FXS)

  • sabatolimabMBG453Phase 21 trial

    Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

  • SAR444836Phase 21 trial

    Sanofi · Phenylketonuria

  • SAR446268Phase 21 trial

    Sanofi · Myotonic Dystrophy

  • SCI-110Phase 21 trial

    Neurothera Labs Inc. · Tourette Syndrome

  • SFL-0821Phase 21 trial

    Soufflé Therapeutics, Inc. · Facioscapulohumeral Muscular Dystrophy (FSHD)

  • SP-420Phase 21 trial

    Pharmacosmos A/S · Beta Thalassemia Major Anemia, Myelodysplastic Syndrome

NewerPage 5 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.